GNFT - GENFIT Operating income before deduction of amortization

Graphic logo of genfit.com (GNFT)

The competent French management of Genfit S.A. (GNFT) effectively manages intellectual property and transparent partnership revenues. EBITDA confirms this potential, where the 0.00 level records fresh values. Risks are associated with the dependence on a narrow niche of rare liver pathology therapies and the maintenance of a scientific advantage during clinical trials.

GNFT (GENFIT) Operating profit EBITDA history from 11/23/2025 to 12/06/2025

GENFIT (GNFT) - metric breakdowns and financial figures

- stock price and consensus target price:
Price Chart Genfit SA|GNFT - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Genfit S.A.|GNFT - Real Price to Acquire Entire Company
- balance sheet equity data:
Net Assets per Single Share Genfit S.A.|GNFT - Book Capitalization|Market-to-Book Ratio genfit.com|GNFT - Aggregate Company Assets
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio Genfit S.A.|GNFT - Long-Term Debt to Capital|Short-Term Indebtedness to Equity Genfit SA|GNFT - Company Aggregate Debts|Debts to Book Value Genfit S.A.|GNFT - Company Long-Term Debt|Company Short-Term Indebtedness Genfit S.A.|Critical Liquidity Ratio genfit.com
- net income and valuation multiples indicators:
GNFT - Net Profit|Company Profit Forecast Genfit S.A.|GNFT - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Genfit SA|GNFT - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Genfit S.A.|GNFT - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Genfit S.A.|GNFT - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months genfit.com|GNFT - Earnings growth in current year|Earnings growth forecast for next year Genfit S.A.
- sales revenue and business income indicators:
GNFT - Company Sales|Company Future Sales Genfit SA|GNFT - P/S Multiple|Projected Price to Revenue Genfit S.A.
Summary company analytics:Genfit S.A.
Brand item of Genfit SA

This metric measures the actual cash flow from core operations before taxes and interest, excluding any accounting assumptions. The current value of 0.00 reflects the ability of Genfit S.A. (GNFT) to monetize the drug Iqirvo and license payments, which allows for an assessment of the biopharmaceutical business's resilience to market shocks and commercialization efficiency through the EBITDA_Co trend.

Competitors of Genfit S.A. (GNFT)

Arrowhead Corp - Profit before payment of interest, taxes and amortization|Mirum Pharmaceuticals - Operating profit EBITDA|Operating income before deduction of amortization Dynavax Technologies Corp DVAX|ABUS (Arbutus Biopharma Corporation) - Operating profit before deduction of amortization|IVA (Inventiva SA) - Profit before payment of interest, taxes and amortization|GYRE (Gyre Corp) - Operating profit EBITDA|Profit before interest, taxes and amortization Assembly Corp ASMB|Profit before payment of interest, taxes and amortization Galectin Therapeutics (GALT)|DRRX (durect.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ALGS (Aligos Therapeutics, Inc.)|Operating profit before depreciation charges BioVie Inc|Galmed Pharma - Operating profit EBITDA|Profit before interest, taxes and amortization ENDRA Corp|hepionpharma.com (HEPA) - Profit before payment of interest, taxes and amortization